Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension - Gaine, Sean; Chin, Kelly; Coghlan, Gerry; Channick, Richard; Di Scala, Lilla; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Lang, Irene M.; McLaughlin, Vallerie; Preiss, Ralph; Rubin, Lewis J.; Simonneau, Gérald; et al. (The European respiratory journal, 2017)
Keywords: Acetamides - administration & dosage; Acetamides - adverse effects; Adult; Antihypertensive Agents - administration & dosage; Antihypertensive Agents - adverse effects; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Hypertension, Pulmonary - diagnosis; Hypertension, Pulmonary - drug therapy; Hypertension, Pulmonary - etiology; Hypertension, Pulmonary - mortality; Lung diseases; Lupus Erythematosus, Systemic - complications; Male; Middle Aged; Morbidity; Mortality; Original; Outcome Assessment (Health Care); Prostacyclin; Pulmonary hypertension; Pyrazines - administration & dosage; Pyrazines - adverse effects; Risk Assessment; Scleroderma, Systemic - complications; Survival Analysis; Systemic lupus erythematosus; Systemic sclerosis